27 results
8-K
EX-1.1
SLNO
Soleno Therapeutics Inc
7 May 24
Soleno Therapeutics Announces Pricing of Approximately $138 Million Public Offering of Common Stock
5:28pm
or supplier of the Company or any affiliate of the Company, on the other hand, which is required by the Securities Act or the Exchange Act
8-K
EX-1.1
SLNO
Soleno Therapeutics Inc
29 Sep 23
Entry into a Material Definitive Agreement
4:55pm
of the Company, on the one hand, and any director, officer, shareholder, customer or supplier of the Company or any affiliate of the Company, on the other hand
8-K
EX-1.1
SLNO
Soleno Therapeutics Inc
16 Jul 21
Entry into a Material Definitive Agreement
4:14pm
unlawfully (A) a customer or supplier of the Company or any Subsidiary to alter the customer’s or supplier’s level or type of business with the Company
8-K
EX-1.1
SLNO
Soleno Therapeutics Inc
26 Jun 20
Soleno Therapeutics Announces Pricing of $50 Million Public Offering of Common Stock
4:31pm
, shareholder, customer or supplier of the Company or any affiliate of the Company, on the other hand, which is required by the Securities Act
424B3
k2n58hgo66yx4 0cvrt
24 Jul 17
Prospectus supplement
12:00am
424B3
absstt kq
14 Oct 15
Prospectus supplement
12:00am
424B3
boww 2xrgq
14 Oct 15
Prospectus supplement
12:00am
424B3
tsgv8v yh
14 Oct 15
Prospectus supplement
12:00am